• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于生物医学应用的工程 mRNA 递药系统。

Engineered mRNA Delivery Systems for Biomedical Applications.

机构信息

Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, China.

Institute of Organoids on Chips Translational Research, Henan Academy of Sciences, Zhengzhou, 450009, China.

出版信息

Adv Mater. 2024 Apr;36(15):e2308029. doi: 10.1002/adma.202308029. Epub 2024 Feb 8.

DOI:10.1002/adma.202308029
PMID:37805865
Abstract

Messenger RNA (mRNA)-based therapeutic strategies have shown remarkable promise in preventing and treating a staggering range of diseases. Optimizing the structure and delivery system of engineered mRNA has greatly improved its stability, immunogenicity, and protein expression levels, which has led to a wider range of uses for mRNA therapeutics. Herein, a thorough analysis of the optimization strategies used in the structure of mRNA is first provided and delivery systems are described in great detail. Furthermore, the latest advancements in biomedical engineering for mRNA technology, including its applications in combatting infectious diseases, treating cancer, providing protein replacement therapy, conducting gene editing, and more, are summarized. Lastly, a perspective on forthcoming challenges and prospects concerning the advancement of mRNA therapeutics is offered. Despite these challenges, mRNA-based therapeutics remain promising, with the potential to revolutionize disease treatment and contribute to significant advancements in the biomedical field.

摘要

基于信使 RNA(mRNA)的治疗策略在预防和治疗各种疾病方面显示出了显著的前景。优化工程化 mRNA 的结构和递送系统极大地提高了其稳定性、免疫原性和蛋白表达水平,这使得 mRNA 治疗药物的应用范围更广。本文首先深入分析了 mRNA 结构优化策略,并详细描述了递送系统。此外,还总结了 mRNA 技术在生物医学工程方面的最新进展,包括其在抗击传染病、治疗癌症、提供蛋白质替代疗法、进行基因编辑等方面的应用。最后,对 mRNA 治疗药物发展所面临的挑战和前景进行了展望。尽管存在这些挑战,但基于 mRNA 的治疗方法仍然具有广阔的前景,有可能彻底改变疾病治疗方式,并为生物医学领域的重大进步做出贡献。

相似文献

1
Engineered mRNA Delivery Systems for Biomedical Applications.用于生物医学应用的工程 mRNA 递药系统。
Adv Mater. 2024 Apr;36(15):e2308029. doi: 10.1002/adma.202308029. Epub 2024 Feb 8.
2
mRNA delivery via non-viral carriers for biomedical applications.通过非病毒载体进行的mRNA递送在生物医学中的应用。
Int J Pharm. 2021 Sep 25;607:121020. doi: 10.1016/j.ijpharm.2021.121020. Epub 2021 Aug 17.
3
Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.用于细胞内 mRNA 递送和基因组编辑的可生物降解脂质纳米粒子的开发。
Acc Chem Res. 2021 Nov 2;54(21):4001-4011. doi: 10.1021/acs.accounts.1c00500. Epub 2021 Oct 20.
4
Advancements and challenges in mRNA and ribonucleoprotein-based therapies: From delivery systems to clinical applications.基于mRNA和核糖核蛋白的疗法的进展与挑战:从递送系统到临床应用
Mol Ther Nucleic Acids. 2024 Aug 19;35(3):102313. doi: 10.1016/j.omtn.2024.102313. eCollection 2024 Sep 10.
5
Advances in Development of mRNA-Based Therapeutics.基于信使核糖核酸的治疗药物的研发进展。
Curr Top Microbiol Immunol. 2022;440:147-166. doi: 10.1007/82_2020_222.
6
Intracellular Delivery of mRNA for Cell-Selective CRISPR/Cas9 Genome Editing using Lipid Nanoparticles.利用脂质纳米颗粒实现细胞选择性 CRISPR/Cas9 基因组编辑的 mRNA 细胞内递送。
Chembiochem. 2023 May 2;24(9):e202200801. doi: 10.1002/cbic.202200801. Epub 2023 Mar 30.
7
Complex Coacervates as a Promising Vehicle for mRNA Delivery: A Comprehensive Review of Recent Advances and Challenges.复杂凝聚体作为 mRNA 递送的有前途载体:最新进展和挑战的综合综述。
Mol Pharm. 2023 Sep 4;20(9):4387-4403. doi: 10.1021/acs.molpharmaceut.3c00439. Epub 2023 Aug 10.
8
Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment.纳米颗粒基 mRNA 递送至癌症治疗的范围和挑战。
Arch Pharm Res. 2022 Dec;45(12):865-893. doi: 10.1007/s12272-022-01418-x. Epub 2022 Nov 24.
9
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery.传递信使:治疗性 mRNA 递送技术的进展。
Mol Ther. 2019 Apr 10;27(4):710-728. doi: 10.1016/j.ymthe.2019.02.012. Epub 2019 Feb 19.
10
Synthetic modified messenger RNA for therapeutic applications.用于治疗应用的合成修饰信使 RNA。
Acta Biomater. 2021 Sep 1;131:1-15. doi: 10.1016/j.actbio.2021.06.020. Epub 2021 Jun 13.

引用本文的文献

1
Construction of Nanotube-Shaped mRNA Vehicles Using Self-Assembling Peptides.利用自组装肽构建纳米管形状的信使核糖核酸载体
Methods Mol Biol. 2025;2965:403-416. doi: 10.1007/978-1-0716-4742-4_20.
2
Synthesis of sensitive oligodeoxynucleotides containing acylated cytosine, adenine, and guanine nucleobases.含酰化胞嘧啶、腺嘌呤和鸟嘌呤核碱基的敏感寡脱氧核苷酸的合成。
DNA (Basel). 2025 Jun;5(2). doi: 10.3390/dna5020025. Epub 2025 May 9.
3
Recent Advances in mRNA Delivery Systems for Cancer Therapy.用于癌症治疗的mRNA递送系统的最新进展
Adv Sci (Weinh). 2025 Aug;12(29):e17571. doi: 10.1002/advs.202417571. Epub 2025 May 20.
4
Advancing mRNA vaccines for infectious diseases: key components, innovations, and clinical progress.推进用于传染病的信使核糖核酸疫苗:关键组成部分、创新与临床进展
Essays Biochem. 2025 May 1;69(2):EBC20253009. doi: 10.1042/EBC20253009.
5
Developing mRNA Nanomedicines with Advanced Targeting Functions.开发具有先进靶向功能的信使核糖核酸纳米药物。
Nanomicro Lett. 2025 Feb 21;17(1):155. doi: 10.1007/s40820-025-01665-9.
6
A Serum Multi-Parametric Analysis Identifies an Early Innate Immune Signature Associated to Increased Vaccine-Specific Antibody Production and Seroconversion in Simultaneous COVID-19 mRNA and Cell-Based Quadrivalent Influenza Vaccination.血清多参数分析确定了一种早期先天免疫特征,该特征与同时接种新冠病毒mRNA疫苗和基于细胞的四价流感疫苗后疫苗特异性抗体产生增加及血清转化相关。
Vaccines (Basel). 2024 Sep 13;12(9):1050. doi: 10.3390/vaccines12091050.
7
mRNA vaccine designs for optimal adjuvanticity and delivery.mRNA 疫苗设计用于最佳佐剂和传递。
RNA Biol. 2024 Jan;21(1):1-27. doi: 10.1080/15476286.2024.2333123. Epub 2024 Mar 26.